Clarifying and Imaging Candida albicans Biofilms.


Journal

Journal of visualized experiments : JoVE
ISSN: 1940-087X
Titre abrégé: J Vis Exp
Pays: United States
ID NLM: 101313252

Informations de publication

Date de publication:
06 03 2020
Historique:
entrez: 24 3 2020
pubmed: 24 3 2020
medline: 20 9 2020
Statut: epublish

Résumé

The microbial fungus Candida albicans can undergo a change from commensal colonization to virulence that is strongly correlated with its ability to switch from yeast-form growth to hyphal growth. Cells initiating this process become adherent to surfaces as well as to each other, with the resulting development of a biofilm colony. This commonly occurs not only on mucosal tissue surfaces in yeast infections, but also on medical implants such as catheters. It is well known that biofilm cells are resistant to antifungal drugs, and that cells that shed from the biofilm can lead to dangerous systemic infections. Biofilms range from heavily translucent to opaque due to refractive heterogeneity. Therefore, fungal biofilms are difficult to study by optical microscopy. To visualize internal structural, cellular, and subcellular features, we clarify fixed intact biofilms by stepwise solvent exchange to a point of optimal refractive index matching. For C. albicans biofilms, sufficient clarification is attained with methyl salicylate (n = 1.537) to enable confocal microscopy from apex to base in 600 µm biofilms with little attenuation. In this visualization protocol we outline phase contrast refractometry, the growth of laboratory biofilms, fixation, staining, solvent exchange, the setup for confocal fluorescence microscopy, and representative results.

Identifiants

pubmed: 32202525
doi: 10.3791/60718
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI067703
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI100270
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI135178
Pays : United States

Auteurs

Frederick Lanni (F)

Department of Biological Sciences, Carnegie Mellon University; lanni@cmu.edu.

Katherine Lagree (K)

Department of Biological Sciences, Carnegie Mellon University.

Manning Y Huang (MY)

Department of Biological Sciences, Carnegie Mellon University.

Lan Yan (L)

Department of Pharmacology, Second Military Medical University.

Carol A Woolford (CA)

Department of Biological Sciences, Carnegie Mellon University.

Aaron P Mitchell (AP)

Department of Biological Sciences, Carnegie Mellon University.

Articles similaires

T-Lymphocytes, Regulatory Lung Neoplasms Proto-Oncogene Proteins p21(ras) Animals Humans

Pathogenic mitochondrial DNA mutations inhibit melanoma metastasis.

Spencer D Shelton, Sara House, Luiza Martins Nascentes Melo et al.
1.00
DNA, Mitochondrial Humans Melanoma Mutation Neoplasm Metastasis

Prevalence and implications of fragile X premutation screening in Thailand.

Areerat Hnoonual, Sunita Kaewfai, Chanin Limwongse et al.
1.00
Humans Fragile X Mental Retardation Protein Thailand Male Female
Humans Receptors, Antigen, T-Cell Proto-Oncogene Proteins p21(ras) Pancreatic Neoplasms T-Lymphocytes

Classifications MeSH